Results 241 to 250 of about 96,811 (318)

Polymer-Free Versus Biodegradable Polymer Drug-Eluting Stents in Coronary Artery Disease: Updated Systematic Review and Meta-Analysis of Clinical, Angiographic, and OCT Outcomes. [PDF]

Biomedicines
Marchetta M, Sasso S, Paragliola V, Parato AG, De Angelis D, Russo G, Albano G, Benedetto D, Moretti F, Valenti F, Massaro G, Chiricolo G, Tesauro M, Sangiorgi GM.   +13 more
europepmc   +1 more source

Balloon Angioplasty and Drug Eluting Stenting for Treatment of Peripheral Arterial Occlusive Disease

, 2010
Ak›n İzgi
openalex   +1 more source

Characteristics and Predictors of Drug-Eluting Stent Thrombosis - Results From the Multicenter Korea Stent Thrombosis (KoST)' Registry -

, 2011
Kyung Woo Park, Seok‐Jae Hwang, Dong‐A Kwon, Byung‐Hee Oh, Young-Bae Park, In‐Ho Chae, Hyeon‐Cheol Gwon, Seung‐Jung Park, Ki Bae Seung, Taehoon Ahn, Junghan Yoon, Yangsoo Jang, Myung Ho Jeong, Seung‐Jea Tahk, Hyo‐Soo Kim, The Korea Stent Thrombosis Investigators   +15 more
openalex   +2 more sources

Drug-eluting stents versus bare-metal stents for intracranial atherosclerotic stenosis: a systematic review and meta-analysis. [PDF]

BMJ Open
Gong H, Luo J, Xu W, Wang J, Yang R, Yang B, Ma Y, Wang T, Jiao L.   +8 more
europepmc   +1 more source

Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

, 2014
Tuomas Kiviniemi, Marja Puurunen, Axel Schlitt, Andrea Rubboli, Pasi P. Karjalainen, Wail Nammas, Paulus Kirchhof, Fausto Biancari, Gregory Y.H. Lip, Juhani Airaksinen   +9 more
openalex   +2 more sources

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

New England Journal of Medicine, 2007
B. Lagerqvist, S. James, U. Stenestrand, J. Lindbäck, T. Nilsson, L. Wallentin   +5 more
semanticscholar   +1 more source

Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty: A Long-Term in-Stent Restenosis Study. [PDF]

J Am Heart Assoc
von Koch S, Zhou M, Rosén HC, Zwackman S, Jurga J, Grimfjärd P, Götberg M, Mohammad MA, Erlinge D.   +8 more
europepmc   +1 more source

Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trial. [PDF]

Neth Heart J
Renkens MPL, Grundeken MJD, Kerkmeijer LSM, Kraak RP, Kalkman DN, van der Schaaf RJ, Hofma SH, Arkenbout KEK, Weevers APJD, Koch KT, Onuma Y, Serruys PW, Tijssen JGP, de Winter RJ, Wykrzykowska JJ, Tijssen RYG.   +15 more
europepmc   +1 more source

Monocyte to high-density lipoprotein cholesterol ratio predicts restenosis of drug-eluting stents in patients with unstable angina pectoris. [PDF]

Sci Rep
Meng H, Zhou X, Li L, Liu Y, Liu Y, Zhang Y.   +5 more
europepmc   +1 more source

Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years. [PDF]

Pharmacoecon Open
Ploumen EH, Wolcherink MJO, Buiten RA, Pinxterhuis TH, Doggen CJM, Schotborgh CE, Danse PW, Scholte M, van Houwelingen KG, Zocca P, Pouwels XGLV, von Birgelen C.   +11 more
europepmc   +1 more source